Albireo Pharma Inc. (NASDAQ: ALBO) stock closed at 32.92 per share at the end of the most recent trading day (a 1.64% change compared to the prior day closing price) with a volume of 195.66K shares and market capitalization of 613.94M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 90 people. Albireo Pharma Inc. CEO is Ronald H.W. Cooper.

The one-year performance of Albireo Pharma Inc. stock is 82.19%, while year-to-date (YTD) performance is -12.24%. ALBO stock has a five-year performance of 188.77%. Its 52-week range is between 17 and 49, which gives ALBO stock a 52-week price range ratio of 47.25%

Albireo Pharma Inc. currently has a PE ratio of -5.00, a price-to-book (PB) ratio of 3.55, a price-to-sale (PS) ratio of 90.32, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -46.26%, a ROC of -48.75% and a ROE of -76.16%. The company’s profit margin is -%, its EBITDA margin is -672.60%, and its revenue ttm is $6.76 Million , which makes it $0.35 revenue per share.

Of the last four earnings reports from Albireo Pharma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-1.72 for the next earnings report. Albireo Pharma Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Albireo Pharma Inc. is Strong Buy (1), with a target price of $73, which is +125.03% compared to the current price. The earnings rating for Albireo Pharma Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Albireo Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Albireo Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.86, ATR14 : 2.08, CCI20 : -88.48, Chaikin Money Flow : -0.18, MACD : -1.43, Money Flow Index : 35.63, ROC : -3.74, RSI : 50.51, STOCH (14,3) : 22.94, STOCH RSI : 1.00, UO : 34.48, Williams %R : -77.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Albireo Pharma Inc. in the last 12-months were: Jan P. Mattsson (Option Excercise at a value of $39 330), Jan P. Mattsson (Sold 41 470 shares of value $1 615 184 ), Jason G. Duncan (Option Excercise at a value of $84 140), Jason G. Duncan (Sold 4 382 shares of value $193 072 ), Martha Carter (Option Excercise at a value of $886 380), Martha Carter (Sold 40 000 shares of value $1 669 550 ), Pamela Stephenson (Sold 1 308 shares of value $45 171 ), Patrick Taylor Horn (Sold 382 shares of value $10 854 ), Simon N.R. Harford (Sold 292 shares of value $9 815 )